Global Scans · Genetics · Weekly Summary

• [New] Mezigdomide, a second-generation cereblon E3 ligase modulator, is designed to degrade key transcription factors in hematopoietic cell development and differentiation, has the potential to change the multiple myeloma landscape. PharmaLive
• [New] Looking ahead to 2030, the integration of AI and genomics will fundamentally reshape healthcare delivery. BUSINESS 2.0 NEWS
• [New] With a projected 32.6% CAGR through 2029 and genome sequencing costs plummeting toward $200, AI-powered genomics is reshaping personalized medicine, drug discovery, and clinical diagnostics across the global healthcare ecosystem. BUSINESS 2.0 NEWS
• [New] The Veterans Health Administration - VA's healthcare arm - does not have a formal mechanism to identify, track, or resolve risks associated with generative AI. Nextgov/FCW
• [New] Stat: Vertex's CRISPR Sickle Cell Treatment Faces A Costly Bottleneck Vertex executives warned that Casgevy, its curative treatment for sickle cell disease, would be slow to reach patients. KFF Health News
• [New] Different regions of the United States face varying combinations of weather risks, generation portfolios, and regulatory frameworks that influence their adaptation strategies for extreme weather events. Discovery Alert
• [New] Advances in surveillance, genomic sequencing, artificial intelligence-enabled epidemic intelligence, and equitable access to vaccines, diagnostics, and treatments have improved the world's ability to detect and respond to emerging threats more rapidly. fundsforNGOs News - Grants and Resources for Sustainabi
• [New] The potential for BCI to impact various industries such as robotics, medicine and biotech has generated a growing amount of interest and excitement. Investing News Network (INN)
• [New] The causal mechanism linking ASI to takeover risk centers on recursive self-improvement, where an AI approaching human-level generality initiates feedback loops that accelerate its own enhancement. Grokipedia
• [New] AI-Assisted Security Patching and Remediation: By 2027, 70% of corrective code fixes for application security issues will be generated by AI-assisted automated remediation tools, reducing the time to patch software vulnerability down to days. IDC: The premier global market intelligence company
• [New] 68% and 73% of AI-generated code samples, respectively, contained vulnerabilities when manually reviewed. Codebridge
• [New] OpenAI is gearing up for a major IPO in 2026, with an expected valuation of $500 billion, positioning itself as a leader in generative AI. Mean CEO's BLOG
• [New] As troughing across mid-latitude North America is generally forecast to expand westward later in the month, increased chances of below normal temperatures extends westward to the Upper Mississippi Valley and eastern areas of the Northern Plains. EconCurrent's Substack
• [New] OpenAI could acquire a general purpose humanoid startup. AI Supremacy
• [New] The National Transport Authority has announced the rolling out of the Next Generation Ticketing programme, which will allow passengers to pay for public transport fares using bank cards, mobile phones, and other smart devices. Trinity News
• [New] From gene therapies to digital diagnostics, the future of life sciences will be shaped by personalised care, data-driven insights, and global collaboration. ACA
• [New] By application, the rare & genetic diseases segment is expanding at a significant CAGR between 2026 and 2035. Precedence Research
• [New] The genetic bottleneck in U.S. honey bee populations poses long-term sustainability risks. My Site
• [New] In light of the IND clearance, GenEditBio plans to launch a phase 1/2 clinical trial entitled CLARITY, with enrolment activities expected to begin in the second quarter of 2026. CGTlive
• [New] By ensuring that prescribed drugs align with an individual's genetic profile, personalized medicine may decrease trial-and-error prescribing, lower adverse events, and ultimately help control escalating pharmacy costs projected to increase by over 10% in 2026. eclipsewellness.net
• [New] In the long term, AGenDA data will help build African genetic reference databases used for disease research, genetic testing, and medicine worldwide. EurekAlert!
• [New] There has been major progress in recent years in gene editing and other forms of gene therapy to target genetic risk factors directly. ScienceDaily

Last updated: 08 February 2026